Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Gross Profit (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Gross Profit for 16 consecutive years, with $6.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Gross Profit fell 2.93% to $6.1 million in Q4 2025 year-over-year; TTM through Nov 2025 was $24.2 million, a 0.63% increase, with the full-year FY2025 number at $24.2 million, up 0.63% from a year prior.
  • Gross Profit was $6.1 million for Q4 2025 at Cryo Cell International, up from $6.0 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $6.3 million in Q4 2024 to a low of $4.8 million in Q1 2021.
  • A 5-year average of $5.6 million and a median of $5.7 million in 2023 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: fell 12.33% in 2021, then grew 12.07% in 2022.
  • Cryo Cell International's Gross Profit stood at $5.0 million in 2021, then grew by 12.07% to $5.6 million in 2022, then grew by 4.05% to $5.9 million in 2023, then grew by 7.53% to $6.3 million in 2024, then dropped by 2.93% to $6.1 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Gross Profit are $6.1 million (Q4 2025), $6.0 million (Q3 2025), and $6.1 million (Q2 2025).